Latest Breaking News On - Genefusion panel - Page 1 : comparemela.com

Press release Biocartis Group NV: Four Abstracts Showing

PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress.

Region flamandeComunidad autonoma de catalunaUnited statesUnited kingdomArndt hartmann erlangenSergi clavRoger moodyErnest nadal lhospitaletLee robertson birminghamBiocartis idylla genefusionGenefusion panelCompany or biocartisEuropean society of molecular oncologyExchange commissionNeither the companyBiocartis group

Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)

Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomComunidad autonoma de catalunaRegion flamandeRoger moodyIndiens wirtschaftIdylla genefusionSergi clavArndt hartmann erlangenIhre chancenErnest nadal lhospitaletLee robertson birminghamBiocartis idylla genefusionCompany or biocartisEuropean society of molecular oncologyNeither the company

Point of Care Molecular Diagnostics Market worth $3 4 billion

/PRNewswire/ The point of care molecular diagnostics industry is poised for significant growth and advancements in the near future. With the increasing.

United statesUnited kingdomAsia pacificAashish mehraBinx health incThermo fisher scientific incLucira health incInfection ji panelVisby medical incOpgen incRoche ltdQuidel corporationProduct serviceProcurement departmentQuantumdx group ltdDanaher corporation

Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY

PRESS RELEASE: REGULATED INFORMATION17 January 2023, 17:40 CET BIOCARTIS MEETS 2022 KEY OBJECTIVES Mechelen, Belgium, 17 January 2023 - Biocartis Group.

Region flamandeUnited statesHerman verrelstHepatopredict ophiomicsAstrazeneca tagrissoRenate degraveNeither the companyCompany or biocartisBiocartis groupHead of corporate communications investor relations biocartisGenefusion panelExchange commissionEuronext brusselsChief executive officerAverage sales priceNext generation sequencing

Press release Biocartis Group NV: Biocartis Announces Launch of its Rapid CE-marked IVD Idylla™ GeneFusion Panel for Fast Treatment Decisions in Lung Cancer

Press release Biocartis Group NV: Biocartis Announces Launch of its Rapid CE-marked IVD Idylla™ GeneFusion Panel for Fast Treatment Decisions in Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Region flamandeUnited statesUnited kingdomHerman verrelstMdx idyllaRenate degraveNeither the companyCompany or biocartisBiocartis groupHead of corporate communications investor relations biocartisGenefusion panelExchange commissionAnnounces launchGenefusion panelforfasttreatment decisionsEuronext brusselsChief executive officer